Skip to main content

Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026.

Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.02
+9.13 (3.81%)
AAPL  258.83
-0.37 (-0.14%)
AMD  255.07
+8.24 (3.34%)
BAC  53.35
+0.00 (0.00%)
GOOG  330.58
+11.37 (3.56%)
META  662.49
+27.96 (4.41%)
MSFT  393.11
+8.74 (2.27%)
NVDA  196.51
+7.20 (3.80%)
ORCL  163.00
+7.38 (4.74%)
TSLA  364.20
+11.78 (3.34%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.